A pan-cancer analysis of the oncogenic role of ribonucleotide reductase subunit M2 in human tumors
Background Recent studies have identified ribonucleotide reductase subunit M2 (RRM2) as a putative promoter of tumors. However, no systematic analysis of its carcinogenicity has been conducted. Methods The potential functions of RRM2 in various tumor types were investigated using data from the Genot...
Main Authors: | Yaqun Li, Wenhuan Fu, Zikai Geng, Yun Song, Xionggang Yang, Tianye He, Jian Wu, Bin Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
PeerJ Inc.
2022-11-01
|
Series: | PeerJ |
Subjects: | |
Online Access: | https://peerj.com/articles/14432.pdf |
Similar Items
-
Comprehensive Landscape of RRM2 with Immune Infiltration in Pan-Cancer
by: Zijian Zhou, et al.
Published: (2022-06-01) -
Regulatory Role of Ribonucleotide Reductase Subunit M2 in Hepatocyte Growth and Pathogenesis of Hepatitis C Virus
by: Bouchra Kitab, et al.
Published: (2023-01-01) -
Gambogic acid sensitizes gemcitabine efficacy in pancreatic cancer by reducing the expression of ribonucleotide reductase subunit-M2 (RRM2)
by: Guanggai Xia, et al.
Published: (2017-08-01) -
Ribonucleotide reductase small subunit M2 is a master driver of aggressive prostate cancer
by: Ying Z. Mazzu, et al.
Published: (2020-08-01) -
A pan-cancer analysis of the prognostic implication and oncogenic role of tubulin epsilon and delta complex 2 (TEDC2) in human tumors
by: Yang Liu, et al.
Published: (2024-01-01)